Centre hospitalier de Lens
- Address
- 99 Bassée road, 62300 Lens, France
Centre hospitalier de Lens - Multidisciplinary Clinical Research
The Centre hospitalier de Lens is a comprehensive medical research center engaged in diverse clinical investigations spanning oncology, hematology, infectious diseases, and critical care medicine. The institution demonstrates expertise in complex therapeutic interventions and participates in international collaborative research networks, contributing to evidence-based treatment protocols across multiple medical specialties.
- Hematologic malignancies including multiple myeloma and polycythemia vera, evaluating novel combination therapies and minimal residual disease outcomes
- Gastrointestinal oncology focusing on ampullary adenocarcinoma with advanced adjuvant chemotherapy regimens
- Respiratory tract infections and community-acquired pneumonia through adaptive platform trial methodologies
- Critical care immunology investigating prevention of secondary infections in ICU patients with sustained immunosuppression
The center's research portfolio reflects commitment to personalized medicine approaches and precision oncology, particularly in evaluating targeted therapies for rare cancers and blood disorders. Through participation in phase III multicenter trials, the institution contributes to defining optimal treatment strategies for vulnerable patient populations, including elderly patients with newly diagnosed malignancies and critically ill patients experiencing ICU-acquired immunosuppression.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 6 therapeutic areas and 15 of 35 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 5 by active trials.
- 1AstraZeneca AB1active
lock +4 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre hospitalier de Lens
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Oseltamivir and Drug Combinations in Hospitalized Patients with Acute Respiratory Tract Infection: A Randomized Adaptive Platform Trial | Universitair Medisch Centrum Utrecht | Phase III | Recruiting | Feb 2016 | — |
IMP list
lock Showing 1 of 35 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dexamethasone | 2 | Unknown | 2016-02-19 | 2021-06-11 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.